Overview
Ariel Barkan is an Endocrinologist practicing medicine in Ann Arbor, Michigan.
Dr. Barkan is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Acromegaly, Pituitary Tumor, Gigantism, Acromegaloid Facial Appearance Syndrome, and Hormone Replacement Therapy (HRT).
He is actively involved in clinical research, co-authoring 62 peer reviewed articles and participating in 1 clinical trial. Dr. Barkan is currently accepting new patients.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
1500 E Medical Center Dr # 2, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Endocrine Oncology Clinic
Dr. Richard Auchus is a professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND) and Chief of the Endocrinology & Metabolism Section at the Ann Arbor VA Medical Center. He received his medical degree and Ph.D. in pharmacology from Washington University in St. Louis. Then Dr. Auchus completed a residency at the University of Iowa and an endocrinology fellowship at UTHSC-San Antonio/Wilford Hall Medical Center. Dr. Auchus came to UMHS from the Graduate School of Biomedical Sciences in Southwestern Medical School, University of Texas, where he was a Professor of Internal Medicine - Endocrinology.Dr. Auchus is a steroid biologist with expertise both in basic science and clinical/translational science. His work has included translational research into: molecular and genetic mechanisms of human hypertension, improved diagnostic studies and management in primary aldosteronism and Cushing syndromes, modifier genes in 21-hydroxylase deficiency, cardiovascular disease in polycystic ovary syndrome, and the endocrinology of traumatic brain injury. Dr. Auchus is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Congenital Adrenal Hyperplasia (CAH), Intersex, Isolated ACTH Deficiency, Hormone Replacement Therapy (HRT), and Orchiectomy. Dr. Auchus is board certified in Endocrinology, Diabetes & Metabolism. Dr. Auchus is currently accepting new patients.
Rogel Cancer Center
Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is highly rated in 105 conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Endocrinology, Diabetes & Metabolism and Internal Medicine. Dr. Else is currently accepting new patients.
Rogel Cancer Center
Dr. Adina Turcu completed her Internal Medicine residency at Norwalk Hospital/Yale University, CT, where she also served a year as Chief Resident. She completed her Endocrinology fellowship at Mayo Clinic, Rochester, MN, where she was the recipient of the Randall G. Sprague Award for outstanding clinical, investigative, and academic achievement in Endocrinology.Dr. Turcu pursued a postdoctoral fellowship at the University of Michigan, prior to joining the UoM faculty team in the Division of Metabolism, Endocrinology & Diabetes. Her research work focuses on adrenal disorders, including congenital adrenal hyperplasia, Cushing’s syndrome, primary aldosteronism, and pheochromocytoma/paraganglioma. Dr. Turcu is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Hyperaldosteronism, Congenital Adrenal Hyperplasia (CAH), Adrenal Gland Adenoma, Ovarian Overproduction of Androgens, and Hormone Replacement Therapy (HRT). Dr. Turcu is board certified in Endocrinology, Diabetes & Metabolism. Dr. Turcu is currently accepting new patients.
Domino's Farms
Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy. Dr. Oral is board certified in Endocrinology, Diabetes & Metabolism. Dr. Oral is currently accepting new patients.
Endocrine Oncology Clinic
Megan R. Haymart, MD is Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. She holds the Nancy Wigginton Endocrinology Research Professorship of Thyroid Cancer and is Director of Thyroid Cancer Research at the University of Michigan. Dr. Haymart received her medical degree at Johns Hopkins University School of Medicine and completed her internal medicine residency at Johns Hopkins Hospital. She then completed a fellowship in endocrinology, diabetes, and metabolism at the University of Wisconsin. She has been faculty at the University of Michigan since 2009.Dr. Haymart has a history of NIH-funded research focused on optimizing thyroid care delivery. She is a health services researcher who primarily studies thyroid cancer care across the disease continuum: from the diagnosis of a thyroid nodule to cancer survivorship. In recognition of her research, she received the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland (2017), the University of Michigan’s Jerome Conn Award for Research Excellence (2017), membership to American Society for Clinical Investigation (2018), the AACE Hossein Gharib Education Lectureship Award for exemplary contributions to an individual profession or area of expertise (2021), and the inaugural AACE Endocrine Care Innovation Award in recognition of her team’s outstanding body of work focused on clinical outcomes or health care delivery (2025).Dr. Haymart is actively involved in improving research infrastructure at the University of Michigan. This includes her roles as Assistant Director of Data Solutions for AI & Digital Health Innovation, faculty support for MICHR, and co-Director of Patient’s First. She also devotes time to mentoring junior faculty and trainees resulting in her receipt of the MICHR Distinguished Clinical and Translational Research Mentor Award (2021) and the Women in Thyroidology and American Thyroid Association Woman of the Year Award (2021) for promoting the advancement of women, both within the organization and field. Dr. Haymart is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Thyroid Nodule, Papillary Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT). Dr. Haymart is board certified in Endocrinology, Diabetes & Metabolism. Dr. Haymart is currently accepting new patients.
Rogel Cancer Center
Gary D. Hammer, M.D., Ph.D. is Professor in Departments of InternalMedicine (MEND), Cell & Developmental Biology, and Molecular &Integrative Physiology. He currently serves as Director of EndocrineOncology Program in Rogel Cancer Center where he holds the MillieSchembechler Professorship in Adrenal Cancer. He is past Director ofCenter for Organogenesis: Stem Cells & Regenerative Medicine. He hasbrokered the recent renaissance of the current Michigan team of adrenalscientists that includes a who’s who in the study of adrenal disease.He received the UofM Jerome Conn Award for Outstanding Research inInternal Medicine, the Endocrine Society Edwin B. Astwood Award forOutstanding Research and is a member of ASCI and AAP. He has served innumerous leadership roles at UofM and in the public and private sectorsincluding recent tenure on Board of Scientific Advisors for NCI. He isthe editor of four textbooks including Pathophysiology of Disease: AnIntroduction to Clinical Medicine (McGraw Hilll), and the upcomingAdrenal Section Editor for Degroot’s Endocrinology (Elsevier). He hasserved in numerous capacities for the world’s largest endocrineorganization, the Endocrine Society including his most recent role asPresident of the Society (2020-2021). An Advisor to the CongressionalH.E.L.P. committee - he co-authored the 21st Century Cancer ALERT(Access to Life-Saving Early detection, Research and Treatment) Act’’ lintroduced in Congress in 2009. He has been catalyst for the formationof two international cooperative groups, most recently the A5 (AmericanAustralian Asian Adrenal Alliance) that leverages collaboration tosecure projects from Pharma and funding agencies across the spectrum ofadrenal diseases. He is a cofounder of two companies - MILLENDO andSLING THERAPEUTICS that focus on rare endocrine diseases. Dr. Hammer is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Hereditary Neuroblastoma, and Neuroblastoma. Dr. Hammer is board certified in Endocrinology, Diabetes & Metabolism. Dr. Hammer is currently accepting new patients.
Frequently Asked Questions about Dr. Ariel L. Barkan
How do I make an appointment with Dr. Ariel L. Barkan?
You can book an appointment with Dr. Ariel L. Barkan by calling their office at 734-936-5020. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ariel L. Barkan a top-rated expert for Acromegaly?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ariel L. Barkan is classified as an Elite expert for Acromegaly, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ariel L. Barkan specialize in?
While Dr. Ariel L. Barkan is a Endocrinology, they have specific expertise in Acromegaly, Pituitary Tumor, and Gigantism. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.
Does Dr. Ariel L. Barkan participate in research or clinical trials?
Yes. Dr. Ariel L. Barkan has published 62 articles and abstracts on conditions like Acromegaly. You can view a list of Dr. Ariel L. Barkan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Ariel L. Barkan accept my insurance?
Dr. Ariel L. Barkan accepts most major insurance plans, including Blue Cross Blue Shield. We recommend calling the office directly at 734-936-5020 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AcromegalyDr. Barkan isElite. Learn about Acromegaly.
- Pituitary TumorDr. Barkan isElite. Learn about Pituitary Tumor.
- Distinguished
- Acromegaloid Facial Appearance SyndromeDr. Barkan isDistinguished. Learn about Acromegaloid Facial Appearance Syndrome.
- GigantismDr. Barkan isDistinguished. Learn about Gigantism.
- Hypertrichosis-Acromegaloid Facial Appearance Syndrome
- Hypothalamic TumorDr. Barkan isDistinguished. Learn about Hypothalamic Tumor.
- Sotos SyndromeDr. Barkan isDistinguished. Learn about Sotos Syndrome.
- Advanced
- Cushing's diseaseDr. Barkan isAdvanced. Learn about Cushing's disease.
- Growth Hormone Deficiency (GHD)Dr. Barkan isAdvanced. Learn about Growth Hormone Deficiency (GHD).
- HypogonadismDr. Barkan isAdvanced. Learn about Hypogonadism.
- HypopituitarismDr. Barkan isAdvanced. Learn about Hypopituitarism.
- ProlactinomaDr. Barkan isAdvanced. Learn about Prolactinoma.
- Sheehan SyndromeDr. Barkan isAdvanced. Learn about Sheehan Syndrome.
- Experienced
- Addison's DiseaseDr. Barkan isExperienced. Learn about Addison's Disease.
- Adrenal Insufficiency PediatricDr. Barkan isExperienced. Learn about Adrenal Insufficiency Pediatric.
- CraniopharyngiomaDr. Barkan isExperienced. Learn about Craniopharyngioma.
- Cushing's syndromeDr. Barkan isExperienced. Learn about Cushing's syndrome.
- Cushing's syndrome due to Adrenal TumorDr. Barkan isExperienced. Learn about Cushing's syndrome due to Adrenal Tumor.
- Deafness Hypogonadism SyndromeDr. Barkan isExperienced. Learn about Deafness Hypogonadism Syndrome.
- Empty Sella SyndromeDr. Barkan isExperienced. Learn about Empty Sella Syndrome.
- Exogenous Cushing's syndromeDr. Barkan isExperienced. Learn about Exogenous Cushing's syndrome.
- Familial Glucocorticoid DeficiencyDr. Barkan isExperienced. Learn about Familial Glucocorticoid Deficiency.
- Glucocorticoid ResistanceDr. Barkan isExperienced. Learn about Glucocorticoid Resistance.
- Hormone Replacement Therapy (HRT)Dr. Barkan isExperienced. Learn about Hormone Replacement Therapy (HRT).
- HypoaldosteronismDr. Barkan isExperienced. Learn about Hypoaldosteronism.
- Hypogonadotropic HypogonadismDr. Barkan isExperienced. Learn about Hypogonadotropic Hypogonadism.
- InfertilityDr. Barkan isExperienced. Learn about Infertility.
- Isolated ACTH DeficiencyDr. Barkan isExperienced. Learn about Isolated ACTH Deficiency.
- Isolated Hypogonadotropic HypogonadismDr. Barkan isExperienced. Learn about Isolated Hypogonadotropic Hypogonadism.
- Kallmann SyndromeDr. Barkan isExperienced. Learn about Kallmann Syndrome.
- PanhypopituitarismDr. Barkan isExperienced. Learn about Panhypopituitarism.
- Pediatric Growth Hormone DeficiencyDr. Barkan isExperienced. Learn about Pediatric Growth Hormone Deficiency.
- Pituitary ApoplexyDr. Barkan isExperienced. Learn about Pituitary Apoplexy.
- Rathke Cleft CystDr. Barkan isExperienced. Learn about Rathke Cleft Cyst.
- Short Stature (Growth Disorders)Dr. Barkan isExperienced. Learn about Short Stature (Growth Disorders).
- Triple A SyndromeDr. Barkan isExperienced. Learn about Triple A Syndrome.




